245 related articles for article (PubMed ID: 32380376)
1. The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre.
Davies P; Reuber M; Grunewald R; Howell S; Dickson J; Dennis G; Shanmugarajah P; Tsironis T; Brockington A
Seizure; 2020 Jul; 79():8-13. PubMed ID: 32380376
[TBL] [Abstract][Full Text] [Related]
2. Is the Medicines and Healthcare products Regulator Agency (MHRA) guidance on sodium valproate acceptable to women of childbearing age?
Morrison I; Cork H; Smith P; Campbell C; Megan McTiernan M; White K
J R Coll Physicians Edinb; 2020 Jun; 50(2):114-117. PubMed ID: 32568279
[TBL] [Abstract][Full Text] [Related]
3. Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study.
Gaudio M; Konstantara E; Joy M; van Vlymen J; de Lusignan S
BMC Pregnancy Childbirth; 2022 Jan; 22(1):73. PubMed ID: 35086478
[TBL] [Abstract][Full Text] [Related]
4. Valproate risk form-Surveying 215 clinicians involving 4775 encounters.
Angus-Leppan H; Moghim MM; Cock H; Kinton L; Synnott Wells M; Shankar R
Acta Neurol Scand; 2020 Jun; 141(6):483-490. PubMed ID: 32072612
[TBL] [Abstract][Full Text] [Related]
5. Why do some women with epilepsy use valproic acid despite current guidelines? A single-center cohort study.
Bosak M; Słowik A; Turaj W
Epilepsy Behav; 2019 Sep; 98(Pt A):1-5. PubMed ID: 31299525
[TBL] [Abstract][Full Text] [Related]
6. Valproate in the treatment of epilepsy in girls and women of childbearing potential.
Tomson T; Marson A; Boon P; Canevini MP; Covanis A; Gaily E; Kälviäinen R; Trinka E
Epilepsia; 2015 Jul; 56(7):1006-19. PubMed ID: 25851171
[TBL] [Abstract][Full Text] [Related]
7. Treatment decisions in women of childbearing age on valproate.
Harris L; Lowes O; Angus-Leppan H
Acta Neurol Scand; 2020 Apr; 141(4):287-293. PubMed ID: 31883101
[TBL] [Abstract][Full Text] [Related]
8. [Position Statement of Hungarian Epilepsy League: The use of valproate preparations for epilepsy in pregnancy and in women of childbearing age].
Janszky J;
Ideggyogy Sz; 2015 Mar; 68(3-4):143. PubMed ID: 26434203
[No Abstract] [Full Text] [Related]
9. Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy.
Bhakta J; Bainbridge J; Borgelt L
Epilepsy Behav; 2015 Nov; 52(Pt A):212-7. PubMed ID: 26460786
[TBL] [Abstract][Full Text] [Related]
10. National compliance with UK wide guidelines for usage of valproate in women of childbearing potential.
Eriksson SH; Tittensor P; Sisodiya SM
Seizure; 2022 May; 98():8-12. PubMed ID: 35395505
[TBL] [Abstract][Full Text] [Related]
11. Antiepileptic Drug Treatment Patterns in Women of Childbearing Age With Epilepsy.
Kim H; Faught E; Thurman DJ; Fishman J; Kalilani L
JAMA Neurol; 2019 Jul; 76(7):783-790. PubMed ID: 30933252
[TBL] [Abstract][Full Text] [Related]
12. Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience-a European perspective.
Toledo M; Mostacci B; Bosak M; Jedrzejzak J; Thomas RH; Salas-Puig J; Biraben A; Schmitz B
J Neurol; 2021 Aug; 268(8):2735-2748. PubMed ID: 32239268
[TBL] [Abstract][Full Text] [Related]
13. A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.
Paton C; Cookson J; Ferrier IN; Bhatti S; Fagan E; Barnes TRE
BMJ Open; 2018 Apr; 8(4):e020450. PubMed ID: 29654033
[TBL] [Abstract][Full Text] [Related]
14. Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?
Macfarlane A; Greenhalgh T
BMC Pregnancy Childbirth; 2018 Jun; 18(1):200. PubMed ID: 29859057
[TBL] [Abstract][Full Text] [Related]
15. Did advice on the prescription of sodium valproate reduce prescriptions to women? An observational study in three European countries between 2007 and 2016.
Charlton R; Damase-Michel C; Hurault-Delarue C; Gini R; Loane M; Pierini A; Puccini A; Neville A; Snowball J; Morris JK;
Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1519-1528. PubMed ID: 31452307
[TBL] [Abstract][Full Text] [Related]
16. Weighing the risks of valproate in women who could become pregnant.
Angus-Leppan H; Liu RSN
BMJ; 2018 Apr; 361():k1596. PubMed ID: 29669717
[No Abstract] [Full Text] [Related]
17. Prevalence of valproate prescriptions in women of childbearing age in certain regions of Russia.
Kostev K; Osina G; Rider F; Guekht A
Epilepsy Behav; 2019 Dec; 101(Pt A):106584. PubMed ID: 31675601
[TBL] [Abstract][Full Text] [Related]
18. Role of valproate across the ages. Treatment of epilepsy in adults.
Ben-Menachem E; Schmitz B; Tomson T; Vajda F
Acta Neurol Scand Suppl; 2006; 184():14-27. PubMed ID: 16776493
[TBL] [Abstract][Full Text] [Related]
19. Best practice guidelines for the management of women with epilepsy.
Crawford P
Epilepsia; 2005; 46 Suppl 9():117-24. PubMed ID: 16302885
[TBL] [Abstract][Full Text] [Related]
20. Women with epilepsy in childbearing age: Pregnancy-related knowledge, information sources, and antiepileptic drugs.
Friedrich L; Sruk A; Bielen I
Epilepsy Behav; 2018 Mar; 80():122-128. PubMed ID: 29414541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
